AR
CL icon

Apeiron RIA’s Colgate-Palmolive CL Stock Holding History

Apeiron RIA’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,316
Closed -$212K – 209
2025
Q4 		$212K Buy
+2,316
New +$182K 0.04% 201
2025
Q3 		– Sell
-7,327
Closed -$666K – 214
2025
Q2 		$666K Sell
7,327
-266
-4% -$24.3K 0.17% 104
2025
Q1 		$711K Sell
7,593
-152
-2% -$13.6K 0.22% 92
2024
Q4 		$704K Buy
7,745
+379
+5% +$36.2K 0.2% 92
2024
Q3 		$765K Buy
7,366
+348
+5% +$35.5K 0.22% 79
2024
Q2 		$681K Buy
7,018
+237
+3% +$21.9K 0.21% 83
2024
Q1 		$611K Buy
6,781
+72
+1% +$6.1K 0.18% 99
2023
Q4 		$535K Sell
6,709
-28
-0.4% -$2.1K 0.17% 102
2023
Q3 		$479K Buy
6,737
+590
+10% +$44.1K 0.16% 100
2023
Q2 		$474K Buy
6,147
+477
+8% +$36.9K 0.16% 97
2023
Q1 		$426K Buy
5,670
+238
+4% +$17.7K 0.15% 102
2022
Q4 		$428K Buy
5,432
+124
+2% +$9.3K 0.16% 102
2022
Q3 		$367K Buy
+5,308
New +$416K 0.17% 99
2022
Q2 		– Sell
-2,917
Closed -$235K – 155
2022
Q1 		$235K Sell
2,917
-159
-5% -$12.6K 0.11% 133
2021
Q4 		$263K Buy
+3,076
New +$240K 0.11% 134

Other funds holding CL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Apeiron RIA's CL Position: Q1 2026 in Review

Apeiron RIA sold out of Colgate-Palmolive (CL) in Q1 2026, closing a stake of 2,316 shares — an estimated $212K sold.

Apeiron RIA first reported a position in CL in Q4 2021 and held it in 15 quarters. The position peaked at $765K in Q3 2024. 1,959 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Apeiron RIA reported no remaining Colgate-Palmolive position as of Q1 2026 after selling out during the quarter.
  • Apeiron RIA sold 2,316 Colgate-Palmolive shares in Q1 2026, an estimated $212K.
  • Apeiron RIA first reported a position in Colgate-Palmolive in Q4 2021 and held it in 15 quarters.
  • Apeiron RIA's Colgate-Palmolive position peaked at $765K in Q3 2024.
  • 1,959 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Apeiron RIA's 13F filing for Q1 2026, filed 27 Apr 2026.